| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/23/2009 | US20090186887 Novel pyrimidothienoindazoles |
| 07/23/2009 | US20090186886 Tricyclic 1,2,4-Triazine Oxides and Compositions for Therapeutic Use in Cancer Treatments |
| 07/23/2009 | US20090186877 Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors |
| 07/23/2009 | US20090186871 Tyrosine kinase inhibitors |
| 07/23/2009 | US20090186868 Taxane Compound Having Azetidine Ring Structure |
| 07/23/2009 | US20090186864 Ruthenium (ii) compounds |
| 07/23/2009 | US20090186846 Methods to reprogram splice site selection in pre-messenger RNAs |
| 07/23/2009 | US20090186837 Anti-neoplastic compositions comprising extracts of black cohosh |
| 07/23/2009 | US20090186835 Treatment and prophylaxis of cancer |
| 07/23/2009 | US20090186833 Method for producing pectin hydrolysis products |
| 07/23/2009 | US20090186829 Nitrosation-Inducible Inhibitors Biological Macromolecules |
| 07/23/2009 | US20090186802 Cell Penetrating Peptide Conjugates for Delivering of Nucleic Acids into a Cell |
| 07/23/2009 | US20090186801 Methods of Inhibiting Tumor Cell Aggressiveness Using The Microenvironment of Human Embryonic Stem Cells |
| 07/23/2009 | US20090186409 Compositions and methods for the diagnosis and treatment of tumor |
| 07/23/2009 | US20090186338 Oligonucleotides originating from sequences coding for the surface component of ptlv envelope proteins and their uses |
| 07/23/2009 | US20090186099 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 07/23/2009 | US20090186051 Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof |
| 07/23/2009 | US20090186042 Identification and use of novopeptides for the treatment of cancer |
| 07/23/2009 | US20090186036 Anti-Alpha V Beta 6 Antibodies |
| 07/23/2009 | US20090186035 Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| 07/23/2009 | US20090186031 Compositions and methods for treating osteolytic disorders comprising mmp-14 binding proteins |
| 07/23/2009 | US20090186030 Antibodies that bind both bcma and taci |
| 07/23/2009 | US20090186007 Use of cells derived from adipose tissue for the preparation of an anti-tumor medicament |
| 07/23/2009 | US20090186003 Herpes simplex virus expressing foreign genes and method for treating cancers therewith |
| 07/23/2009 | US20090186000 Use of thymosin alpha 1 for preparing a medicament for the treatment of stage iv malignant melanoma |
| 07/23/2009 | US20090185999 Derivatives of gefitinib |
| 07/23/2009 | US20090185996 Hydroxyethyl starch-containing polypeptide compositions |
| 07/23/2009 | DE102008005493A1 4-(Pyrrolo[2,3-c] pyridine-3-yl)-pyrimidin-2-yl-amin-derivate 4- (pyrrolo [2,3-c] pyridine-3-yl) -pyrimidin-2-yl-amine derivatives |
| 07/23/2009 | DE102008005097A1 Herstellung und Verwendung antitumoraler Cyclodepsipeptide Production and use of anti-tumor cyclodepsipeptides |
| 07/23/2009 | CA2755876A1 Synthesis of resorcylic acid lactones useful as therapeutic agents |
| 07/23/2009 | CA2712443A1 6- and 7-amino isoquinoline compounds and methods for making and using the same |
| 07/23/2009 | CA2712408A1 Platinum complex compound and utilization of the same |
| 07/23/2009 | CA2712367A1 Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments |
| 07/23/2009 | CA2712267A1 3h-[1,2,3]triazolo[4,5-d]pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 07/23/2009 | CA2712118A1 Pterin based therapies for inflammatory conditions |
| 07/23/2009 | CA2711931A1 Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological applications thereof |
| 07/23/2009 | CA2711902A1 Combination of an anti-edb fibronectin antibody-il-2 fusion protein, and a molecule binding to b cells, b cell progenitors and/or their cancerous counterpart |
| 07/23/2009 | CA2711737A1 6,7-dialkoxy quinazoline derivatives useful for treatment of cancer related disorders |
| 07/23/2009 | CA2711690A1 Solid forms of ortataxel |
| 07/23/2009 | CA2711532A1 Agent for prevention of alcoholic hepatopathy |
| 07/23/2009 | CA2711514A1 Pyridazine fungicides |
| 07/23/2009 | CA2710619A1 Inhibiting angiogenesis using egfl8 antagonists |
| 07/23/2009 | CA2708559A1 Treatment of colon diseases or prevention of colorectal carcinoma with imidazoquinoline derivatives |
| 07/22/2009 | EP2080804A1 Modified cytokines for use in cancer therapy |
| 07/22/2009 | EP2080802A2 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 07/22/2009 | EP2080779A1 Polymeric derivative of nucleic acid metabolic antagonist |
| 07/22/2009 | EP2080771A2 New interferon beta-like molecules |
| 07/22/2009 | EP2080764A1 Solid forms of ortataxel |
| 07/22/2009 | EP2080763A1 Crystalline form I of ortataxel |
| 07/22/2009 | EP2080525A1 Remodeling and Glycoconjugation of Peptides |
| 07/22/2009 | EP2080524A1 Pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex and its preparing process |
| 07/22/2009 | EP2080516A1 Use of isothiocyanate derivatives as anti-myeloma agents |
| 07/22/2009 | EP2080512A1 Anti-cancer agent |
| 07/22/2009 | EP2079840A1 Immunotox n fusions comprising an antibody fragment and a plant toxin linked by protease cleavable linkers |
| 07/22/2009 | EP2079833A1 Compositions and methods for immunotherapy |
| 07/22/2009 | EP2079746A2 Imidazopyrazines as protein kinase inhibitors |
| 07/22/2009 | EP2079744A1 Imidazopyridazines as pi3k lipid kinase inhibitors |
| 07/22/2009 | EP2079743A1 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer |
| 07/22/2009 | EP2079742A1 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer |
| 07/22/2009 | EP2079738A2 7-azaindole derivatives as c-met kinase inhibitors |
| 07/22/2009 | EP2079733A2 5- and 6-substituted benzimidazole thiophene compounds |
| 07/22/2009 | EP2079729A1 Compounds and compositions as protein kinase inhibitors |
| 07/22/2009 | EP2079724A2 Substituted pyridone compounds and methods of use |
| 07/22/2009 | EP2079719A1 Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents |
| 07/22/2009 | EP2079704A2 Therapeutic compounds |
| 07/22/2009 | EP2079702A1 3-amino-pyrazole-4-carboxamide derivatives useful as inhibitors of protein kinases |
| 07/22/2009 | EP2079700A1 18, 21-didesoxymacbecin derivatives for the treatment of cancer |
| 07/22/2009 | EP2079698A1 Caspase inhibitors based on pyridazinone scaffold |
| 07/22/2009 | EP2079691A1 Substituted indeno[1,2-b]indole derivatives as novel inhibitors of protein kinase ck2 and their use as tumour therapeutic agents, cytostatics and diagnostic aids |
| 07/22/2009 | EP2079527A2 Use of deuterium dioxide for treating hyperproliferative skin diseases |
| 07/22/2009 | EP2079486A2 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 07/22/2009 | EP2079380A1 Method of treating cancer comprising introduction of heat and delivery of liposome containing an active agent or thermo-activated drug, gene or virus to tissue |
| 07/22/2009 | EP2079304A1 Amine base salts of saha and polymorphs thereof |
| 07/22/2009 | EP2006377A9 Novel tumor antigen peptides |
| 07/22/2009 | EP1928858B1 Solid salt forms of a pyrrole substituted 2-indolinone |
| 07/22/2009 | EP1713830B1 Anti-epcam immunoglobulins |
| 07/22/2009 | EP1678169B1 4-(pyrazol-3-ylamino)pyrimidine derivatives for use in the treatment of cancer |
| 07/22/2009 | EP1667996B1 Quinazoline derivatives |
| 07/22/2009 | EP1567524B1 Thia-epothilone derivatives for the treatment of cancer |
| 07/22/2009 | EP1517684B1 Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy |
| 07/22/2009 | EP1503988B1 Fredericamycin derivatives |
| 07/22/2009 | EP1443053B1 Analgesic antitumor peptide from scorpion and method of producing it |
| 07/22/2009 | EP1432791B1 Alphavirus replicon vector systems |
| 07/22/2009 | EP1392680B1 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3 |
| 07/22/2009 | EP1392241B1 System for osmotic delivery of pharmaceutically active agents |
| 07/22/2009 | EP1391456B1 2-iminoimidazole derivatives |
| 07/22/2009 | EP1379224B1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 07/22/2009 | EP1280900B1 Dendritic cell co-stimulatory molecules |
| 07/22/2009 | EP1263719B1 N-deacetylthiocolchine derivatives and pharmaceutical compositions containing them |
| 07/22/2009 | EP1255563B1 Composition of antigen and glycolipid adjuvant sublingual administration |
| 07/22/2009 | EP1231840B1 Anti-angiogenic cellular agent for cancer therapy |
| 07/22/2009 | EP1133517B1 INTRANUCLEAR TARGETED DELIVERY OF COMPOUNDS BY 70 kD HEAT SHOCK PROTEIN |
| 07/22/2009 | EP1131461B1 Use of hydroxamate compounds for the treatment of HER-2/neu-positive carcinomas |
| 07/22/2009 | EP1093381B2 Antigenic peptides derived from telomerase |
| 07/22/2009 | EP1044018B1 Tumour vaccines for muc1-positive carcinomas |
| 07/22/2009 | CN101486682A N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/22/2009 | CN100516220C Serine proteinase inhibitor of bifidobacteria |
| 07/22/2009 | CN100516203C In vitro cell culturing method |
| 07/22/2009 | CN100516087C Recombinant target fusion protein GnRH-TNFam and its antitumor use |
| 07/22/2009 | CN100516037C Nitrooxyderivatives of cyclooxygenase-2 inhibitors |